S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)
S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)
S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)
S&P 500   4,981.84 (+0.13%)
DOW   38,611.85 (+0.12%)
QQQ   424.94 (-0.56%)
AAPL   182.18 (+0.34%)
MSFT   401.15 (-0.41%)
META   467.44 (-0.81%)
GOOGL   142.61 (+1.06%)
AMZN   168.60 (+0.91%)
TSLA   194.26 (+0.26%)
NVDA   674.00 (-2.95%)
NIO   5.98 (+0.34%)
AMD   164.07 (-0.98%)
BABA   75.38 (+3.06%)
T   16.99 (+0.47%)
F   12.12 (-1.06%)
MU   81.09 (+0.47%)
CGC   3.47 (-1.98%)
GE   148.47 (-0.10%)
DIS   107.54 (-1.74%)
AMC   4.55 (-2.36%)
PFE   27.60 (+0.04%)
PYPL   57.46 (-2.00%)
XOM   104.69 (+1.89%)

Pediatrix Medical Group (MD) Competitors

$8.70
+0.24 (+2.84%)
(As of 03:51 PM ET)

MD vs. ABVX, CVAC, GRCL, ORIC, TRML, PHAR, CGEM, ZNTL, EOLS, and SLRN

Should you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include ABIVAX Société Anonyme (ABVX), CureVac (CVAC), Gracell Biotechnologies (GRCL), ORIC Pharmaceuticals (ORIC), Tourmaline Bio (TRML), Pharming Group (PHAR), Cullinan Oncology (CGEM), Zentalis Pharmaceuticals (ZNTL), Evolus (EOLS), and Acelyrin (SLRN). These companies are all part of the "medical" sector.

Pediatrix Medical Group vs.

Pediatrix Medical Group (NYSE:MD) and ABIVAX Société Anonyme (NASDAQ:ABVX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation.

96.9% of Pediatrix Medical Group shares are held by institutional investors. 2.0% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Pediatrix Medical Group has higher revenue and earnings than ABIVAX Société Anonyme.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pediatrix Medical Group$1.97B0.37$66.33M$1.137.75
ABIVAX Société AnonymeN/AN/AN/AN/AN/A

Pediatrix Medical Group presently has a consensus target price of $14.30, suggesting a potential upside of 69.13%. ABIVAX Société Anonyme has a consensus target price of $17.50, suggesting a potential upside of 42.86%. Given Pediatrix Medical Group's higher possible upside, equities analysts plainly believe Pediatrix Medical Group is more favorable than ABIVAX Société Anonyme.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pediatrix Medical Group
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
ABIVAX Société Anonyme
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Pediatrix Medical Group had 13 more articles in the media than ABIVAX Société Anonyme. MarketBeat recorded 16 mentions for Pediatrix Medical Group and 3 mentions for ABIVAX Société Anonyme. ABIVAX Société Anonyme's average media sentiment score of 0.39 beat Pediatrix Medical Group's score of 0.39 indicating that ABIVAX Société Anonyme is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pediatrix Medical Group
2 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Neutral
ABIVAX Société Anonyme
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pediatrix Medical Group has a net margin of 4.65% compared to ABIVAX Société Anonyme's net margin of 0.00%. Pediatrix Medical Group's return on equity of 11.70% beat ABIVAX Société Anonyme's return on equity.

Company Net Margins Return on Equity Return on Assets
Pediatrix Medical Group4.65% 11.70% 4.67%
ABIVAX Société Anonyme N/A N/A N/A

Pediatrix Medical Group received 498 more outperform votes than ABIVAX Société Anonyme when rated by MarketBeat users. However, 66.67% of users gave ABIVAX Société Anonyme an outperform vote while only 61.50% of users gave Pediatrix Medical Group an outperform vote.

CompanyUnderperformOutperform
Pediatrix Medical GroupOutperform Votes
500
61.50%
Underperform Votes
313
38.50%
ABIVAX Société AnonymeOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

Summary

Pediatrix Medical Group beats ABIVAX Société Anonyme on 9 of the 13 factors compared between the two stocks.


Get Pediatrix Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MD vs. The Competition

MetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE Exchange
Market Cap$736.02M$3.87B$4.90B$17.15B
Dividend YieldN/A1.33%2.91%3.55%
P/E Ratio7.7511.0090.0021.55
Price / Sales0.370.823,114.095.98
Price / Cash4.628.4488.5017.87
Price / Book0.822.204.286.21
Net Income$66.33M$192.44M$111.45M$866.35M
7 Day Performance-4.16%-1.46%1.96%0.51%
1 Month Performance-6.01%-0.65%7.48%2.72%
1 Year Performance-44.45%-11.14%7.95%68.97%

Pediatrix Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABVX
ABIVAX Société Anonyme
2.0857 of 5 stars
$11.99
-1.7%
$17.50
+46.0%
N/A$754.53MN/A0.0026Positive News
Gap Down
CVAC
CureVac
3.397 of 5 stars
$3.39
-2.9%
$15.00
+342.5%
-61.1%$758.82M$72.33M0.001,049Positive News
GRCL
Gracell Biotechnologies
2.8393 of 5 stars
$10.34
+0.8%
$13.14
+27.1%
+367.6%$751.51M$60,000.00-9.85314Options Volume
News Coverage
ORIC
ORIC Pharmaceuticals
4.0022 of 5 stars
$11.28
-6.0%
$15.86
+40.6%
+121.6%$759.93MN/A-5.6793Gap Down
TRML
Tourmaline Bio
3.5243 of 5 stars
$37.60
+1.0%
$49.75
+32.3%
N/A$764.78MN/A-2.5219Positive News
PHAR
Pharming Group
1.8554 of 5 stars
$11.40
-13.6%
$38.50
+237.7%
-0.2%$765.05M$205.62M-36.77332News Coverage
Gap Down
High Trading Volume
CGEM
Cullinan Oncology
2.5509 of 5 stars
$17.91
-5.8%
$28.00
+56.3%
+53.4%$766.19M$18.94M-4.7962Analyst Revision
ZNTL
Zentalis Pharmaceuticals
1.0189 of 5 stars
$10.83
-5.8%
$38.14
+252.2%
-30.1%$766.44MN/A-2.34156News Coverage
EOLS
Evolus
3.9764 of 5 stars
$13.42
-2.3%
$20.60
+53.5%
+43.4%$767.62M$148.62M-12.09246Gap Down
SLRN
Acelyrin
3.2507 of 5 stars
$7.62
-1.7%
$23.67
+210.6%
N/A$741.73MN/A0.00108News Coverage
Positive News
Gap Down

Related Companies and Tools

This page (NYSE:MD) was last updated on 2/21/2024 by MarketBeat.com Staff